Indication
Non-Muscle Invasive Bladder Cancer
The Non-Muscle Invasive Bladder Cancer pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Non-Muscle Invasive Bladder Cancer, so this list is not complete.
1 Phase 3
Market size not yet sourced. How markets are sized ↗